Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/1998
06/10/1998CA2224351A1 Novel organotin compounds and compositions containing these compounds
06/09/1998US5763582 Derivatives of triterpenoid acids and uses thereof
06/09/1998US5763571 Amino acid sequences which inhibit binding
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763487 Skin disorders, cardiovascular disorders and cosmetics
06/09/1998US5763484 Metabolites of linoleic acid and a-linolenic acid
06/09/1998US5763471 Melatoninergic agonist spiro indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products
06/09/1998US5763453 Antitumor agents
06/09/1998US5763436 Guanidine derivatives
06/09/1998US5763435 Administering to mammal to treat liver disease or inflammatory condition of gastrointestinal tract
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763429 Method of treating prostatic diseases using active vitamin D analogues
06/09/1998US5763428 Administering active nontoxic derivatives for skin or metabolic disorders
06/09/1998US5763426 Dissolving calcipotriol in organic solvent and adding water to the solution to precipitate the hydrate; storage stability; useful for treatment of psoriasis
06/09/1998US5763421 Heparin derivatives having antimetastatic activity
06/09/1998US5763418 Nucleotide antitumor agents
06/09/1998US5763276 Processes for the purification of human recombinant decorin and the detection of guandinium ions
06/09/1998US5763274 Antibody 103B2
06/09/1998US5763250 Chimeric toxins
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5762936 Antioxidant derived from lentil and its preparation and uses
06/09/1998US5762921 Composition and methods for the treatment of tumors
06/09/1998US5762907 Frozen radiopharmaceutical formulations
06/04/1998WO1998023758A1 Human glutathione s-transferase
06/04/1998WO1998023648A1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
06/04/1998WO1998023636A1 Heptapeptide oxytocin analogues
06/04/1998WO1998023625A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998WO1998023617A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998WO1998023616A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998WO1998023614A1 Novel phenanethridinium derivatives
06/04/1998WO1998023613A1 Fused bicyclic pyrimidine derivatives
06/04/1998WO1998023608A1 Novel integrin receptor antagonists
06/04/1998WO1998023607A1 1,4-dihydropyridine derivatives
06/04/1998WO1998023594A1 Cytotrienins, process for preparing the same, and antitumor agent
06/04/1998WO1998023581A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998WO1998023575A1 Asiatic acid derivatives having modified a-ring
06/04/1998WO1998023299A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/04/1998WO1998023279A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
06/04/1998WO1998023269A1 Polythiophene anti-tumor agents
06/04/1998WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
06/04/1998WO1998009948A3 Nitric ester derivatives and their use in urinary incontinence and other diseases
06/04/1998CA2272992A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998CA2272945A1 1,4-dihydropyridine derivatives
06/04/1998CA2272916A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998CA2272915A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998CA2272565A1 Integrin receptor antagonists
06/04/1998CA2272388A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998CA2272275A1 Polythiophene anti-tumor agents
06/04/1998CA2271689A1 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/04/1998CA2223541A1 New imidazoline derivatives, preparation process and the pharmaceutical compositions containing them
06/03/1998EP0845540A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
06/03/1998EP0845539A1 Isolation and purification of tetrahydropyrimidine derivatives
06/03/1998EP0845530A2 Interferon gamma inducing factor
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/03/1998EP0845005A1 Traf inhibitors
06/03/1998EP0845002A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
06/03/1998EP0844885A2 Chemical compounds
06/03/1998EP0844883A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998EP0844873A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
06/03/1998EP0693073B1 Bicyclic ansamycins and their use as antitumor agents
06/03/1998CN1183806A Polynucleotide immunogenic agents
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183774A Trisubstd phenyl derivs
06/03/1998CN1183726A Synthetic cryptophycins
06/03/1998CN1183722A Use of penciclovir for treatment of human herpes-virus-8
06/03/1998CN1183297A Katsutoxin pill for tumor and preparing method thereof
06/03/1998CN1183290A Anticancer drug
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760178 Antitumor
06/02/1998US5760084 Treating dermatological disorders
06/02/1998US5760072 Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
06/02/1998US5760041 4-aminoquinazoline EGFR Inhibitors
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5759808 Immunoglobulins devoid of light chains
06/02/1998US5759783 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759543 Application of a cell culture of a fusarium fungus strain producer for medical uses
06/02/1998US5759514 Composition for delivery of toxic radioisotopes to the cell nucleus and use
06/02/1998CA2012278C Mutant of microbacterium, a strain 851r, and a process for producing 851r nutrient solution by application of the strain
06/02/1998CA1339896C Dideoxydidehydrocarbocyclic nucleosides
05/1998
05/28/1998WO1998022617A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998WO1998022587A2 Pituitary-tumor-transforming-genes, and related products
05/28/1998WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION
05/28/1998WO1998022579A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998WO1998022500A2 Modulation of interactions between myosin and integrins
05/28/1998WO1998022479A1 Pharmaceutical formulations
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022461A1 Epothilone c, d, e and f, production process, and their use as cytostatic as well as phytosanitary agents
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022423A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/28/1998WO1998022418A1 Substituted phenols and thiophenols useful as antioxidant agents
1 ... 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 ... 2211